Importantly, high levels of ClpP expression were associated with shortened distant metastasis-free survival (S2 Table) in patients with breast adenocarcinoma (Fig 5H) and uveal melanoma (Fig 5I) and in abbreviated relapse-free survival in lung adenocarcinoma (Fig 5J). Here, CLPP is linked to breast adenocarcinoma.